Early diagnosis and screening

Invasive Bladder Cancer

Volumn , Issue , 2007, Pages 15-38

  McNally, Melanie L ^a   Rashid, Hani H ^a   Messing, Edward M ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052104251     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84628-377-2_2     Document Type: Chapter

References (62)

1. Jemal A, Thomas A, Murray T and Thun M (2000) Cancer statistics, 2002. Ca: A Cancer Journal for Clinicians 52: 23-4.
2. Lee R and Droller MJ (2000) The natural history of bladder cancer: Implications for therapy. Urologic Clinics of North America 27(1): 1-13.
3. Bostwick DG, Ramnani D and Cheng L (1999) Diagnosis and grading of bladder cancer lesions. Urologic Clinics of North America 26: 493-507.
4. Prout GR Jr, Barton BA, Griffin PP et al. (1992) Treated history of non-invasive grade 1 transitional cell carcinoma. Journal of Urology 148: 1413-9.
5. Heney NM, Ahmed S, Flanagan MJ et al. (1983) Superficial bladder cancer: Progression and recurrence. Journal of Urology 12: 1083-6.
6. Kryger JV and Messing EM (1996) Bladder cancer screening. Seminars in Oncology 23: 585-97.
7. Lamm DL (1998) Bladder cancer: Twenty years of progress and the challenges that remain. CA: A Cancer Journal for Clinicians 48: 263-8.
8. Kaye KW and Lange PH (1982) Mode of presentation of invasive bladder cancer: Reassessment of the problem. Journal of Urology 128: 31-3.
9. Morrison DA, Murphy WM, Ford K and Soloway MS (1984) Surveillance of stage 0, grade I bladder cancer by cytology alone - is it acceptable? Journal of Urology 132: 672-4.
10. Kiemeney LA and Schoenberg M (1996) Familial transitional cell carcinoma. Journal of Urology 156: 867-72.
11. Lynch CF and Cohen MB (1995) Urinary system. Cancer 75(suppl): 316-29.
12. Parkin DM, Pisani P and Ferlay J (1999) Global cancer statistics. Ca: A Cancer Journal for Clinicians 49: 33-64.
13. Droller MJ (1998) Bladder cancer: State of the art care. Ca: A Cancer Journal for Clinicians 48: 269-84.
14. Messing EM (2002) Urothelial tumours of the urinary tract. In: Walsh PC et al. (eds) Campell's Urology. WB Saunders Company: Philadelphia, pp. 2732-84.
15. Morrison AS, Burning JE, Verhock WG et al. (1984) An international study of smoking and bladder cancer. Journal of Urology 131: 650-4.
16. Paz A, Cytron S, Lobik L, Kravchick S and Tikva P (2002) Passive smoking - A risk factor for transitional cell carcinoma of the bladder in patients with hematuria. Journal of Urology 167(suppl): 161.
17. Kunze E, Chang-Claude J and Frentzel-Beyme R (1992) Lifestyle and occupational risk factors for bladder cancer in Germany. A case-control study. Cancer 69: 1776-90.
18. Kiemeney LA, Moret NC, Witjes JA, Schoenberg MP and Tulinius H (1997) Familial transitional cell carcinoma among the population of Iceland. Journal of Urology 157: 1649-51.
19. Hayes RB, Friedell GH, Zahm SH and Cole P (1993) Are the known bladder cancer risk factors associated with more advanced bladder cancer? Cancer Causes Control 4: 157-62.
20. Varkarakis MJ, Gaeta J, Moore RH and Murphy GP (1974) Superficial bladder tumour: Aspects of clinical progression. Urology 4: 414-20.
21. Greene LF, O'Shaughnessy EJ Jr. and Hendricks ED (1956) Study of 500 patients with asymptomatic hematuria. JAMA 161: 610-3.
22. Messing EM, Young TB, Hunt VB et al. (1987) The significance of asymptomatic microhematuria in men 50 or more years old: Findings of a home screening study using urinary dipsticks. Journal of Urology 137: 919-22.
23. Messing EM and Vaillancourt A (1990) Hematuria screening for bladder cancer. Journal of Occupational Medicine 32(9): 838-45.
24. Ramakumar S, Bhuiyan J, Besse JA et al. (1999) Comparison of screening methods in the detection of bladder cancer. Journal of Urology 161: 388-94.
25. Robertson AJ, Beck JS, Burnett RA et al. (1990) Observer variability in histopathologic reporting of transitional cell carcinoma and epithelial dysplasia in bladders. Journal of Clinical Pathology 43: 17-21.
26. Reeder JE, Cox C, Wheeless LL et al. (1997) Variability of DNA analysis by image cytometry. Cytometry 28: 176-80.
27. Wheeless LL, Reeder JE, O'Connell MJ et al. (1991) DNA slit-scan flow cytometry of bladder irrigation specimens and the importance of recognizing urothelial cells. Cytometry 12:140-6.
28. Hemstreet III GP, Hurst RE, Bonner RB, Kong J and Asal N (1999) Biomarkers in the premalignant field predict individual cancer risk. Presented at the American Urologic Association National Meeting.
29. Murphy WM, Emerson LD, Chandler RW, Moinuddin SM and Soloway MS (date) Flow cytometry versus urinary cytology in the evaluation of patients with bladder cancer. Journal of Urology 136: 815-9.
30. Cordon-Cardo C, Reuter VE, Lloyd KO et al. (1988) Blood group-related antigens in human urothelium: Enhanced expression of Lexand Leydeterminants in urothelial carcinoma. Cancer Research 48: 4113-20.
31. Lee E, Schwaibold H, Fradet Y, Huland E and Huland H (1997) Tumour-Associated antigens in normal mucosa of patients with superficial transitional cell carcinoma of the bladder. Journal of Urology 157: 1070-3.
32. Messing EM and Murphy-Brooks N (1994) Recovery of epidermal growth factor in voided urine of patients with bladder cancer. Urology 44: 502-6.
33. Jones A and Crew J (2000) Vascular endothelial growth factor and its correlation with superficial bladder cancer recurrence rates and stage progression. Urologic Clinics of North America 27: 191-7.
34. Stampfer DS, Carpinto GA, Rodriguez-Villanueva J et al. (1998) Evaluation of NMP 22 in the detection of transitional cell carcinoma of the bladder. Journal of Urology 159: 394-8.
35. Ponsky LE, Sharma S, Pandrangi L et al. (2001) Screening and monitoring for bladder cancer: Refining the use of NMP22. Journal of Urology 166: 75-8.
36. Konety BR, Nguyan TS, Brenes G et al. (2000) Clinical usefulness of the novel marker BLCA-4 for the detection of bladder cancer. Journal of Urology 164: 634-69.
37. Malkowicz SB (2000) The application of human complement H-related protein (BTA TRAK) in monitoring patients with bladder cancer. Urologic Clinics of North America 27: 63-73.
38. Ellis WJ, Blumenstein BA, Ishak LM, Enfield DL and the Multi Center Study Group (1997) Clinical evaluation of the BTA TRAK assay and comparison to voided urine cytology and the Bard BTA test in patients with recurrent bladder tumours. Urology 50: 882-7.
39. Liu BCS and Loughlin KR (2000) Telomerase in human bladder cancer. Urologic Clinics of North America 27: 115-23.
40. Ramakumar S, Bhuiyan J, Besse JA et al. (1999) Comparison of screening methods in the detection of bladder cancer. Journal of Urology 161: 388-94.
41. Lokeshwar VB and Block NL (2000) HA-Haase urine test: A sensitive and specific method for detecting bladder cancer and evaluating its grade. Urologic Clinics of North America 27: 53-61.
42. Smith SD, Wheeler MA, Plescia J et al. (2001) Urine detection of survivin and diagnosis of bladder cancer. JAMA 285: 324-8.
43. Jung I, Reeder JE, Messing EM and Wheeless LL (1999) Chromosome 9 monosomy by fluorescence in situ hybridization of bladder irrigation specimens is predictive of tumour recurrence. Journal of Urology 162: 1900-3.
44. Halling KC, King W, Sokolova IA and Meyer RG (2000) A comparison of cytology and fluorescence in situ hybridization for detection of urothelial carcinoma. Journal of Urology 164: 1768-75.
45. Mao L, Lee DJ, Tockman MS et al. (1994) Microsatellite alterations as clonal markers for the detection of human cancer. Proceedings of the National Academy of Sciences 91: 9871-5.
46. Steiner G, Reinschmidt G and Muller SC (1999) Molecular genetic diagnosis of de novo and recurrent bladder cancer. Electrophoresis 20(2): 280-2.
47. Mourah S, Cussenot O, Vimont V et al. (1998) Assessment of microsatellite instability in urine in the detection of transitional cell carcinoma of the bladder. International Journal of Cancer 79: 629-33.
48. Gonzalez-Zulueta M, Ruppert M, Tokino K et al. (1993) Microsatellite instability in bladder cancer. Cancer Research 53: 5620-3.
49. Utting M, Werner W, Muller G, Schubert J and Junker K (2001) A possible non-invasive method for the detection of bladder cancer in patients: Microsatellite analysis of free DNA in urine and blood. Annals of the New York Academy of Sciences 945: 31-5.
50. Fielding JR, Hoyte LX, Okon SA et al. (2002) Tumour detection by virtual cystoscopy with color mapping of bladder wall thickness. Journal of Urology 167: 559-62.
51. Murphy WM, Rivera-Ramirez I, Medina CA, Wright NJ and Wajsman Z (1997) The bladder tumour antigen (BTA) test compared to voided urine cytology in the detection of bladder neoplasms. Journal of Urology 158: 2102-6.
52. Boman H, Hedelin H and Holmang S (2002) Four bladder tumour markers have a disappointingly low sensitivity for small size and low grade recurrence. Journal of Urology 167: 80-3.
53. Messing EM, Young TB, Hunt VB et al. (1989) Urinary tract cancers found by home screening with hematuria dipsticks in healthy men over 50 years of age. Cancer 64: 2361-7.
54. Messing EM, Young TB, Hunt VB et al. (1992) Home screening for hematuria: Results of a multiclinic study. Journal of Urology 148: 289-92.
55. Messing EM, Young TB, Hunt VB et al. (1995) Hematuria home screening: Repeating test results. Journal of Urology 154: 57-61.
56. Messing EM, Young TB, Hunt VB et al. (1995) Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations. Urology 45: 387-96.
57. Britton JP, Dowell AC and Whelan P (1989) Dipstick hematuria and bladder cancer in men over 60: Results of a community study. BMJ 299: 1010-12.
58. Britton JP, Dowell AC, Whelan P and Harris CM (1992) A community study of bladder cancer screening by the detection of occult urinary bleeding. Journal of Urology 148: 788-90.
59. Kim ED and Ignatoff JM (1994) Unsuspected bladder carcinoma in patients undergoing radical prostatectomy. Journal of Urology 152: 397-400.
60. Theriault GP, Tremblay CG and Armstrong BG (1990) Bladder cancer screening among primary aluminum production workers in Québec. Journal of Occupational Medicine 32: 869-72.
61. Hemstreet III GP, Asal N, Bonner R et al. (1997) Individual risk assessment and bladder cancer screening in a benzidine-exposed occupational cohort. Presented at the American Urologic Association National Meeting.
62. Frumin E, Velez H, Bingham E et al. (1990) Occupational bladder cancer in textile dying and printing worker: Six cases and their significance for screening for bladder cancer. Journal of Occupational Medicine 32: 887-90.